Physician

Abraham Wolfenzon, M.D.

According to 2025 Medicare claims, Abraham Wolfenzon, M.D. (NPI: 1922165737) practices cardiology, with the plurality of this provider's patient population coming from Monroe, FL. This provider's primary affiliated billing organization is BAPTIST HEALTH MEDICAL GROUP UPPER KEYS, LLC (NPI: 1558553479; TIN: 205155995) and primary practice location at 33070-2513. Wolfenzon is affiliated with the Baptist Health Quality Network LLC (ACO ID: A5013), participating under the MSSP model.

Wolfenzon's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 583 traditional Medicare patients, billed 1,332 HCPCS/CPT codes, and received $87,551 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,567 prescription claims across 280 beneficiaries totaling $453,554 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 12 claims. Open Payments data shows 1 records totaling $21. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $64,704 to $453,554. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $20,685 to $2,184.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	844	1,523	$50,692
2016	890	1,531	$49,165
2017	820	1,274	$51,653
2018	884	1,463	$61,317
2019	831	1,379	$64,606
2020	796	1,252	$59,252
2021	823	1,290	$64,715
2022	665	1,011	$54,985
2023	483	903	$44,502
2024	583	1,332	$87,551

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	123	787	$64,704
2016	127	798	$78,024
2017	127	773	$109,866
2018	142	905	$173,416
2019	154	819	$142,857
2020	146	755	$161,807
2021	141	718	$186,591
2022	137	788	$202,222
2023	197	1,085	$317,826
2024	280	1,567	$453,554

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	155	259	$14,558
2016	113	293	$11,113
2017	106	271	$6,992
2018	96	220	$6,716
2019	59	150	$5,747
2020	43	116	$3,778
2021	N/R	101	$3,368
2022	N/R	25	$1,082
2023	N/R	12	$225
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	166	166	$150
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	277	403	$114
93016	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician	157	157	$18
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	227	261	$13
93018	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician	157	157	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	172	11,644	$220,000
Entresto	Sacubitril/Valsartan	76	4,818	$100,240
Repatha Sureclick	Evolocumab	48	2,154	$40,837
Xarelto	Rivaroxaban	26	2,142	$38,690
Farxiga	Dapagliflozin Propanediol	11	870	$10,951

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$21	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abraham Wolfenzon, M.D.?

Tedicare shows public-source Medicare data for Abraham Wolfenzon, M.D. (NPI 1922165737), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abraham Wolfenzon, M.D. have ACO affiliation data?

Abraham Wolfenzon, M.D. is shown with ACO affiliation data for Baptist Health Quality Network LLC (MSSP, ACO ID A5013).

What billing organization is linked to Abraham Wolfenzon, M.D.?

Abraham Wolfenzon, M.D. is linked to BAPTIST HEALTH MEDICAL GROUP UPPER KEYS, LLC (billing NPI 1558553479) in the available physician profile data.

Does Abraham Wolfenzon, M.D. have Open Payments data?

Abraham Wolfenzon, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.